Intriguingly, we detected a dramatic change in phosphorylated AKT1 (which significantly increases in circulating T2DM EVs while the total protein level diminishes), and these changes are associated with the change in relevant clinical measures of glycemic control, insulin secretion, and insulin action. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.